Outdated regulations and inflexible sponsor processes are hampering clinical trial recruitment, but empowering sites with ...

Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...

In this video interview, Heather Horville, solutions consultant at Greenphire, discusses how growing financial and logistical ...

The issue came to light after it was exposed that doctors at an Ahmedabad Municipal Corporation hospital had conducted ...

The country’s biggest medicinal cannabis prescriber believes laws should change to broaden access to the drug. But critics ...

Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial ...

Patients with rare diseases are increasingly working to find and fund their own cures. But should they have to?

Currently, PET scanner validation phantoms, methods, and acceptance criteria for clinical trials are not standardized. This ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...